Food, Drugs, Healthcare, Life Sciences

The publication of Baroness Amos's final report and the appointment of a national Maternity and Neonatal Commissioner have reignited a fundamental question that has plagued NHS maternity services for years. With multiple layers of oversight already in place—from regulators and commissioners to national bodies—why does avoidable harm persist, and who actually holds the power to enforce the changes needed to prevent it?

The Amos Report examines whether this latest inquiry into UK maternity care will finally drive meaningful improvement or simply repeat lessons already identified by previous investigations. With decades of warnings about avoidable harm, persistent inequalities, and failures to learn from past mistakes, the report raises critical questions about systemic accountability and the effectiveness of reform efforts. Will this become another report that gathers dust, or a genuine catalyst for safer, more equitable m

May 2026 saw continued momentum across the European Union and United Kingdom toward modernizing and streamlining the regulatory landscape for digital health, with a particular focus on accommodating AI-enabled technologies while reducing unnecessary complexity.